» Articles » PMID: 16311714

Hypermobility Syndrome Increases the Risk for Low Bone Mass

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2005 Nov 29
PMID 16311714
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Few studies on the benign joint hypermobility syndrome suggest a tendency toward osteopenia, but there are conflicting results. We assessed bone mineral density in pre-menopausal women with hypermobility. Twenty-five consecutive Caucasian women diagnosed with benign hypermobility syndrome by Beighton score and 23 age- and sex-matched controls were included in the study. Age, menarch age, number of pregnancies, duration of lactation, physical activity and calcium intake were questioned according to European Vertebral Osteoporosis Study Group (EVOS) form. All subjects were pre-menopausal and none of them were on treatment with any drugs effecting bone metabolism or had any other systemic disease. No statistically significant difference was found for body mass index, menarch age, number of pregnancies, duration of lactation, calcium intake, calcium score and physical activity score between the two groups. Total femoral and trochanteric bone mineral density and t and z scores were significantly lower in hypermobile patients compared to the control group. Ward's triangle and femoral neck z scores were also found to be significantly low in hypermobile patients (p<0.05). Significant negative correlations were found between the Beighton scores and trochanteric BMD, t and z scores (r=-0.29, r=-0.30, and r=-0.32) in hypermobility patients. Low bone mass was more frequently found among subjects with hypermobility (p=0.03). Hypermobility was found to increase the risk for low bone mass by 1.8 times (95% confidence interval 1.01-3.38). Our study suggests that pre-menopausal women with joint hypermobility have lower bone mineral density when compared to the controls and hypermobility increases the risk for low bone mass.

Citing Articles

Hypermobility spectrum disorders: A review.

Carroll M Rheumatol Immunol Res. 2023; 4(2):60-68.

PMID: 37637226 PMC: 10457547. DOI: 10.2478/rir-2023-0010.


Pain in Ehlers-Danlos Syndrome: A Non-Diagnostic Disabling Symptom?.

Guerrieri V, Polizzi A, Caliogna L, Brancato A, Bassotti A, Torriani C Healthcare (Basel). 2023; 11(7).

PMID: 37046863 PMC: 10094213. DOI: 10.3390/healthcare11070936.


Rationale and Feasibility of Resistance Training in hEDS/HSD: A Narrative Review.

Zabriskie H J Funct Morphol Kinesiol. 2022; 7(3).

PMID: 35997377 PMC: 9397026. DOI: 10.3390/jfmk7030061.


Interrater and Intrarater Reliability of the Beighton Score: A Systematic Review.

Bockhorn L, Vera A, Dong D, Delgado D, Varner K, Harris J Orthop J Sports Med. 2021; 9(1):2325967120968099.

PMID: 33786328 PMC: 7960900. DOI: 10.1177/2325967120968099.


Clinical management of benign joint hypermobility syndrome: a case series.

Boudreau P, Steiman I, Mior S J Can Chiropr Assoc. 2020; 64(1):43-54.

PMID: 32476667 PMC: 7250515.


References
1.
Wordsworth P, Ogilvie D, Smith R, Sykes B . Joint mobility with particular reference to racial variation and inherited connective tissue disorders. Br J Rheumatol. 1987; 26(1):9-12. DOI: 10.1093/rheumatology/26.1.9. View

2.
Dolan A, Arden N, Grahame R, Spector T . Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry. Ann Rheum Dis. 1999; 57(10):630-3. PMC: 1752482. DOI: 10.1136/ard.57.10.630. View

3.
Seckin U, Sonel Tur B, Yilmaz O, Yagci I, Bodur H, Arasil T . The prevalence of joint hypermobility among high school students. Rheumatol Int. 2004; 25(4):260-3. DOI: 10.1007/s00296-003-0434-9. View

4.
Harinstein D, Buckingham R, Braun T, Oral K, Bauman D, Killian P . Systemic joint laxity (the hypermobile joint syndrome) is associated with temporomandibular joint dysfunction. Arthritis Rheum. 1988; 31(10):1259-64. DOI: 10.1002/art.1780311007. View

5.
Nijs J, Van Essche E, De Munck M, Dequeker J . Ultrasonographic, axial, and peripheral measurements in female patients with benign hypermobility syndrome. Calcif Tissue Int. 2000; 67(1):37-40. DOI: 10.1007/s00223001093. View